Joint Symposia

EANM is teaming up again with its external partner societies, to fully reflect the multidisciplinarity of Nuclear Medicine.

A preliminary list of planned sessions can be found hereunder. The partner societies will be published after finalization of the corresponding symposium.

 

Joint Symposium 1
Bone & Joint + Inflammation & Infection + Paediatrics Committee / TBA
PET/MRI in MSK – Be Hybrid!

 

Joint Symposium 2
Cardiovascular Committee / TBA
PET-MPI vs. SPECT-MPI – Is it Worth the Price?

 

Joint Symposium 3
Cardiovascular Committee / TBA
MPI after the ISCHEMIA Trial – Still Alive?

 

Joint Symposium 4
Dosimetry Committee / TBA
Biokinetics and Dosimetry in Intraarterial Therapy

 

Joint Symposium 5
Drug Development + Radiopharmacy + Oncology & Theranostics Committee / TBA
Targeting Cancer Cells – Peptides, Fragments or mAb, Which one is the Most Suitable?

 

Joint Symposium 6
Drug Development + Radiopharmacy + Translational Molecular Imaging & Therapy Committee / TBA
Modifying Radiopharmaceuticals to Alter Pharmacokinetics

 

Joint Symposium 7
Inflammation & Infection Committee / EASD
My Foot is on Fire – Find the Hot Spot

Session Details

 

 

Joint Symposium 8
Inflammation & Infection Committee / TBA
PET/CT and PET/MRI in Patients with Autoimmune Disorders

 

Joint Symposium 9
Neuroimaging Committee / TBA
The New ATN Diagnostic Concept in Alzheimer’s Disease

 

Joint Symposium 10
Neuroimaging Committee / TBA
PET/MRI in Epilepsy

 

Joint Symposium 11
Neuroimaging + Oncology & Theranostics Committee / TBA
Advancements in Neuro-Oncology

 

Joint Symposium 12
Oncology & Theranostics Committee / TBA
Nuclear Medicine in Precision Oncology

 

Joint Symposium 13
Oncology & Theranostics Committee / TBA
Biomarkers in Lymphoma

 

Joint Symposium 14
Oncology & Theranostics Committee / TBA
New Therapies in Lymphoma – Is Deauville still Good Enough?

 

Joint Symposium 15
Oncology & Theranostics Committee / TBA
Imaging Challenge Multiple Myeloma – Quo Vadis 2021?

 

Joint Symposium 16
Oncology & Theranostics Committee / TBA
Combination Treatments – What can RLT be Combined With?

 

Joint Symposium 17
Oncology & Theranostics Committee / TBA
What to Do and Not Do in Prostate Imaging

 

Joint Symposium 18
Oncology & Theranostics Committee / TBA
Urological Challenges for Imaging Beyond Prostate

 

Joint Symposium 19
Physics Committee / TBA
Harmonisation and Standardisation

 

Joint Symposium 20
Physics Committee / TBA
Artificial Intelligence for Image Processing and Quantification

 

Joint Symposium 21
Physics Committee / TBA
Numerical and Computer Phantoms

 

Joint Symposium 22
Radiation Protection + Thyroid + Dosimetry Committee / TBA
The MEDIRAD Project – Impact on Nuclear Medicine Practice

 

Joint Symposium 23
Radiation Protection + Technologist Committee /TBA
Extremity Dosimetry – It’s in Your Hands!

 

Joint Symposium 24
Thyroid + Oncology & Theranostics Committee / TBA
Theranostics of Thyroid Cancer – Beyond Radioiodine

 

Joint Symposium 25
Thyroid Committee / TBA
Global Cost-Effectiveness of Different DTC Management Strategies

 

Joint Symposium 26
Translational Molecular Imaging & Therapy Committee / TBA
Imaging Mitochondria and Mitochondrial Dysfunction

 

Joint Symposium 27
Neuroimaging Committee / JSNM
Advances in Molecular Imaging of Neurodegenerative Disorders

Session Details